A. Oliver Sartor, MD | Authors

Articles

Exploring the Design for Longer Follow-Up of Radium-223 in mCRPC

June 04, 2020

A. Oliver Sartor, MD, discusses the design for an observational study of disease characteristics and outcome of patients with metastatic castration-resistant prostate cancer who received 177Lu-PSMA after receiving radium-223.